XML 90 R80.htm IDEA: XBRL DOCUMENT v3.23.3

SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Net sales	$ 3,708	$ 3,609		$ 10,928	$ 10,761
United States
Segment Reporting Information [Line Items]
Net sales	1,766	1,758		5,183	5,170
International
Segment Reporting Information [Line Items]
Net sales	1,942	1,851		5,745	5,591
BPS | Revision of Prior Period, Adjustment
Segment Reporting Information [Line Items]
Net sales		(8)	$ (2)		(26)
Other | Revision of Prior Period, Adjustment
Segment Reporting Information [Line Items]
Net sales		8	2		26
Operating Segments | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	1,258	1,203		3,691	3,567
Operating Segments | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	744	735		2,218	2,205
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	580	525		1,652	1,574
Operating Segments | Kidney Care
Segment Reporting Information [Line Items]
Net sales	1,109	1,100		3,294	3,286
Operating Segments | United States | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	709	708		2,087	2,100
Operating Segments | United States | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	551	548		1,607	1,609
Operating Segments | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	195	173		550	494
Operating Segments | United States | Kidney Care
Segment Reporting Information [Line Items]
Net sales	299	293		883	869
Operating Segments | International | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	549	495		1,604	1,467
Operating Segments | International | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	193	187		611	596
Operating Segments | International | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	385	352		1,102	1,080
Operating Segments | International | Kidney Care
Segment Reporting Information [Line Items]
Net sales	810	807		2,411	2,417
Operating Segments | Infusion Therapies and Technologies | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	1,003	956		2,918	2,829
Operating Segments | Infusion Therapies and Technologies | United States | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	570	567		1,654	1,672
Operating Segments | Infusion Therapies and Technologies | International | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	433	389		1,264	1,157
Operating Segments | Advanced Surgery | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	255	247		773	738
Operating Segments | Advanced Surgery | United States | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	139	141		433	428
Operating Segments | Advanced Surgery | International | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales	116	106		340	310
Operating Segments | Care and Connectivity Solutions | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	443	456		1,307	1,350
Operating Segments | Care and Connectivity Solutions | United States | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	317	339		926	991
Operating Segments | Care and Connectivity Solutions | International | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	126	117		381	359
Operating Segments | Front Line Care | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	301	279		911	855
Operating Segments | Front Line Care | United States | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	234	209		681	618
Operating Segments | Front Line Care | International | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales	67	70		230	237
Operating Segments | Injectables and Anesthesia | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	351	325		987	961
Operating Segments | Injectables and Anesthesia | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	195	173		550	494
Operating Segments | Injectables and Anesthesia | International | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	156	152		437	467
Operating Segments | Drug Compounding | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	229	200		665	613
Operating Segments | Drug Compounding | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	0	0		0	0
Operating Segments | Drug Compounding | International | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	229	200		665	613
Operating Segments | Chronic Renal | Revision of Prior Period, Reclassification, Adjustment
Segment Reporting Information [Line Items]
Net sales		(8)	(16)		(23)
Operating Segments | Chronic Renal | Kidney Care
Segment Reporting Information [Line Items]
Net sales	921	934		2,730	2,744
Operating Segments | Chronic Renal | United States | Kidney Care
Segment Reporting Information [Line Items]
Net sales	233	236		689	675
Operating Segments | Chronic Renal | International | Kidney Care
Segment Reporting Information [Line Items]
Net sales	688	698		2,041	2,069
Operating Segments | Acute Therapies | Revision of Prior Period, Reclassification, Adjustment
Segment Reporting Information [Line Items]
Net sales		8	$ 16		23
Operating Segments | Acute Therapies | Kidney Care
Segment Reporting Information [Line Items]
Net sales	188	166		564	542
Operating Segments | Acute Therapies | United States | Kidney Care
Segment Reporting Information [Line Items]
Net sales	66	57		194	194
Operating Segments | Acute Therapies | International | Kidney Care
Segment Reporting Information [Line Items]
Net sales	122	109		370	348
Other
Segment Reporting Information [Line Items]
Net sales	17	46		73	129
Other | United States
Segment Reporting Information [Line Items]
Net sales	12	36		56	98
Other | International
Segment Reporting Information [Line Items]
Net sales	$ 5	$ 10		$ 17	$ 31

X

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-4

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_BPSMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RestatementAxis=srt_RestatementAdjustmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_OtherMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_MedicalProductsAndTherapiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_HealthcareSystemsAndTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_PharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_KidneyCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_InfusionTherapiesAndTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_CareAndConnectivitySolutionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_FrontLineCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_InjectablesAndAnesthesiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_PharmaceuticalCompoundingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_ChronicRenalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_AcuteTherapiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: